e-learning
resources
Virtual 2021
05.09.2021
Pulmonary rehabilitation in the COVID-19 era
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The assessment of the metabolic dysfunction in patients (pts) after COVID-19 pneumonia
L. Konopkina (Dniepropetrovsk, Ukraine), L. Botvinikova (Dniepropetrovsk, Ukraine), O. Shchudro (Dniepropetrovsk, Ukraine), O. Myronenko (Dniepropetrovsk, Ukraine), O. Plekhanova (Dniepropetrovsk, Ukraine)
Source:
Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Session:
Pulmonary rehabilitation in the COVID-19 era
Session type:
E-poster
Number:
603
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Konopkina (Dniepropetrovsk, Ukraine), L. Botvinikova (Dniepropetrovsk, Ukraine), O. Shchudro (Dniepropetrovsk, Ukraine), O. Myronenko (Dniepropetrovsk, Ukraine), O. Plekhanova (Dniepropetrovsk, Ukraine). The assessment of the metabolic dysfunction in patients (pts) after COVID-19 pneumonia. 603
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Mental disorders in patients (pts) with COVID-19 pneumonia:comparison with COPD exacerbation
Source: Virtual Congress 2021 – Long COVID - 19
Year: 2021
The dynamics of dyspnea in patients (pts) with pneumonia on the background of SARS-CoV2 infection
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021
Myocardial dysfunction in patients (pts) after severe coronavirus disease (COVID-19)
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021
Evaluation of Behcet‘s disease patients who admitted with pulmonary symptoms (analysis of 14 cases)
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Endothelial dysfunction and its corrections in patients with severe community-aquired pneumonia (CAP)
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts)
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 338s
Year: 2003
Detection of liver function in patients with severe community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 15s
Year: 2002
The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010
The influence of co-morbidity on the outcome of non-invasive ventilatory support in patients with acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 277s
Year: 2002
Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR)
Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates
Year: 2008
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Diagnosis on community-acquired pneumonia (CAP) in patients with congestive heart failure (CHF)
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Incorporating patients with chronic heart failure (CHF) into pulmonary rehabilitation (PR): a propensity matched analysis
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP)
Source: International Congress 2014 – Clinical presentations
Year: 2014
Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts)
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Cardiac diseases in patients with community acquired pneumonia (CAP)
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept